Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
August 08, 2025
International Publication of Phase II clinical Trial
International Publication of Phase II clinical Trial
Indication: Androgenetic Alopecia
Manuscript Published In: Cureus Journal of Medical Science
Publisher: Springer Nature
Impact Factor: 1.2
Indexed in: PubMed Central, Web of Science, Google Scholar, etc.
CBCC Global Research: Benchmarked to Global Standards of Excellence!
Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas
ClinicalResearch PharmaceuticalScience Dermatology DrugDevelopment
ClinicalTrials MedicalResearch